Life Science REIT PLC
LSE:LABS
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
31.5
68.6
|
Price Target |
|
We'll email you a reminder when the closing price reaches GBX.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one LABS stock under the Base Case scenario is 57.2 GBX. Compared to the current market price of 42 GBX, Life Science REIT PLC is Undervalued by 27%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Life Science REIT PLC
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for LABS cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Life Science REIT PLC
Balance Sheet Decomposition
Life Science REIT PLC
Current Assets | 16.2m |
Cash & Short-Term Investments | 10.5m |
Receivables | 2.1m |
Other Current Assets | 3.6m |
Non-Current Assets | 386.2m |
Long-Term Investments | 382.6m |
Other Non-Current Assets | 3.6m |
Current Liabilities | 13.5m |
Accounts Payable | 7.7m |
Accrued Liabilities | 1.8m |
Other Current Liabilities | 4m |
Non-Current Liabilities | 121.6m |
Long-Term Debt | 118.1m |
Other Non-Current Liabilities | 3.6m |
Earnings Waterfall
Life Science REIT PLC
Revenue
|
20.1m
GBP
|
Cost of Revenue
|
-5.6m
GBP
|
Gross Profit
|
14.5m
GBP
|
Operating Expenses
|
-5.1m
GBP
|
Operating Income
|
9.4m
GBP
|
Other Expenses
|
-49.5m
GBP
|
Net Income
|
-40m
GBP
|
Free Cash Flow Analysis
Life Science REIT PLC
GBP | |
Free Cash Flow | GBP |
Life Science REIT has demonstrated solid operational performance despite economic challenges, with a 3.9% valuation increase and 7% portfolio occupancy boost to 89%. Adjusted earnings rose by GBP 2.5 million to GBP 3.2 million, primarily from 2022 acquisitions, with excellent rent collection at 99%. Net borrowings stood at GBP 82 million, with adequate liquidity and a 100% hedge against interest rate risk. Sustaining dividend payments, the firm remains well-positioned for growth, aligning with ESG principles, improving data quality for better environmental impact measures, and evolving their strategy towards delivering more Life Science spaces.
What is Earnings Call?
LABS Profitability Score
Profitability Due Diligence
Life Science REIT PLC's profitability score is 40/100. The higher the profitability score, the more profitable the company is.
Score
Life Science REIT PLC's profitability score is 40/100. The higher the profitability score, the more profitable the company is.
LABS Solvency Score
Solvency Due Diligence
Life Science REIT PLC's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Score
Life Science REIT PLC's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
LABS Price Targets Summary
Life Science REIT PLC
According to Wall Street analysts, the average 1-year price target for LABS is 58.82 GBX with a low forecast of 36.36 GBX and a high forecast of 84 GBX.
Dividends
Current shareholder yield for LABS is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Life Science Reit Plc is an investment company, which intends to carry on business as a REIT. The Company’s investment objective is to provide shareholders with a level of total return. The company will seek to achieve its investment objective by investing in a diversified portfolio of properties across the United Kingdom which are leased or intended to be leased to tenants operating in, or providing a benefit to, the life science sector. The company acquires or develops properties, such as wet and dry laboratories, offices, incubators and co-working space, manufacturing and testing facilities and data centers. The company acquires individual buildings, a group of buildings across a single science park or the entirety of a science park. This may include purchasing or developing buildings that are leased or intended to be leased to tenants providing ancillary services to employees of companies operating in, or providing a benefit to, the life science sector. The Company’s investment adviser is Ironstone Asset Management Limited.
Officers
The intrinsic value of one LABS stock under the Base Case scenario is 57.2 GBX.
Compared to the current market price of 42 GBX, Life Science REIT PLC is Undervalued by 27%.